TARS- Tarsus Pharmaceuticals, Inc.

Insider activity in TARS over the last quarter tilts toward selling: insiders offloaded a net 29,850 shares worth roughly $1.8M.

TARS sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Azamian Bobak R.	858.0K	$55.59M	-
Dir	Link William J Phd	108.7K	$7.04M	-
COO	Neervannan Seshadri	79.2K	$5.13M	-
Other	Farrow Jeffrey S	56.8K	$3.68M	-
Other	Whitfield Dianne C.	24.3K	$1.57M	-

Buys and sells only

10 filings · page 12

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 4, 2022	Vivo Capital Ix, LLC57	10% Owner	Sell	512,956	$13.39	$6,866,310.96	-6.1%	+28.9%	+16.8%
Dec 1, 2021	Azamian Bobak R.45	President And CEO	Sell	5,833	$24.72	$144,166.82	-0.1%	-21.4%	-30.4%
Dec 1, 2021	Ackermann Michael76	Director	Sell	5,833	$24.68	$143,934.45	-0.1%	-21.4%	-30.4%
Nov 8, 2021	Mottiwala Aziz51	Chief Commercial Officer	Sell	1,889	$28.11	$53,099.79	-3.6%	-38.9%	-35.6%
Nov 5, 2021	Mottiwala Aziz51	Chief Commercial Officer	Sell	111	$28.04	$3,112.21	-0.1%	-39.2%	-35.5%
Nov 2, 2021	Mottiwala Aziz51	Chief Commercial Officer	Sell	6,000	$26.78	$160,690.36	-5.4%	-24.8%	-34.6%
Nov 1, 2021	Azamian Bobak R.45	President And CEO	Sell	5,833	$27.82	$162,284.08	-0.2%	-29.0%	-36.6%
Nov 1, 2021	Ackermann Michael76	Director	Sell	5,833	$27.82	$162,289.06	-0.2%	-29.0%	-36.6%
Oct 12, 2021	Azamian Bobak R.45	President And CEO	Sell	5,531	$26.30	$145,448.29	-0.2%	-17.3%	-39.1%
Oct 12, 2021	Ackermann Michael76	Director	Sell	5,633	$26.27	$147,999.61	-0.2%	-17.3%	-39.1%